Vladimir P Torchilin Selected Research

phosphatidylethanolamine

1/2018	Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agents.
12/2014	Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors.
4/2014	Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.
2/2014	Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma.
8/2013	The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy.
1/2010	Polymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example.
1/2007	Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents.
9/2003	In vivo biodistribution of erythrocytes and polyethyleneglycol-phosphatidylethanolamine micelles carrying the antitumour agent dequalinium.
8/2003	Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery.
10/2002	Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir P Torchilin Research Topics

Disease

166	Neoplasms (Cancer) 07/2023 - 09/2002
22	Breast Neoplasms (Breast Cancer) 04/2024 - 09/2002
9	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 11/2012
8	Adenocarcinoma 01/2023 - 01/2005
8	Carcinoma (Carcinomatosis) 03/2019 - 01/2005
7	Lewis Lung Carcinoma 01/2009 - 10/2002
6	Myocardial Infarction 04/2012 - 01/2004
5	Brain Neoplasms (Brain Tumor) 04/2023 - 07/2005
4	Melanoma (Melanoma, Malignant) 01/2018 - 05/2012
3	Glioblastoma (Glioblastoma Multiforme) 04/2023 - 03/2009
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2016
3	Infections 03/2021 - 01/2011
3	Infarction (Infarctions) 03/2007 - 01/2004
2	Wounds and Injuries (Trauma) 03/2021 - 02/2019
2	Hypoxia (Hypoxemia) 01/2016 - 04/2012
2	Necrosis 12/2014 - 10/2003
2	Lung Neoplasms (Lung Cancer) 01/2013 - 08/2008
2	Stroke (Strokes) 06/2012 - 08/2003
2	Inflammation (Inflammations) 05/2012 - 01/2010
2	Prostatic Neoplasms (Prostate Cancer) 08/2010 - 08/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2010 - 09/2009
2	Ischemia 09/2009 - 06/2006

Drug/Important Bio-Agent (IBA)

60	Liposomes (Liposome)IBA 07/2023 - 12/2002
55	MicellesIBA 07/2023 - 10/2002
30	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 09/2002
25	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 01/2018 - 10/2002
23	Small Interfering RNA (siRNA)IBA 07/2023 - 05/2006
23	Paclitaxel (Taxol)FDA LinkGeneric 03/2021 - 05/2003
21	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2003
20	LigandsIBA 07/2023 - 07/2005
20	Monoclonal AntibodiesIBA 03/2021 - 07/2005
15	liposomal doxorubicin (Doxil)FDA Link 01/2016 - 09/2002
14	Nucleosomes (Nucleosome)IBA 01/2020 - 11/2004
14	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018 - 10/2002
13	Peptides (Polypeptides)IBA 01/2023 - 03/2003
12	LipidsIBA 07/2023 - 10/2005
10	phosphatidylethanolamineIBA 01/2018 - 10/2002
10	PolymersIBA 05/2017 - 03/2003
9	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 03/2003
8	AntibodiesIBA 01/2020 - 08/2003
7	CurcuminIBA 08/2022 - 12/2013
7	Contrast MediaIBA 01/2018 - 09/2006
7	Transferrin (beta 2 Transferrin)IBA 01/2017 - 01/2012
7	Drug CarriersIBA 01/2010 - 12/2002
6	Phospholipids (Phosphatides)FDA LinkGeneric 07/2023 - 01/2009
6	Adenosine Triphosphate (ATP)IBA 02/2014 - 12/2005
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2022 - 09/2011
5	Dendrimers (Dendrons)IBA 07/2022 - 06/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2003
4	AntigensIBA 04/2023 - 08/2008
4	Therapeutic UsesIBA 02/2023 - 01/2009
4	MicroRNAs (MicroRNA)IBA 08/2022 - 01/2017
4	Green Fluorescent ProteinsIBA 06/2018 - 01/2007
4	Ethanolamine (Colamine)IBA 05/2017 - 01/2004
4	GadoliniumIBA 01/2017 - 01/2006
4	Immunoglobulin G (IgG)IBA 03/2009 - 07/2005
3	Immunoconjugates (Immunoconjugate)IBA 04/2024 - 12/2021
3	salinomycinIBA 07/2023 - 01/2016
3	Cytotoxins (Cytolysins)IBA 04/2023 - 08/2010
3	Cell-Penetrating PeptidesIBA 10/2021 - 01/2007
3	PolyethyleneimineIBA 12/2019 - 01/2012
3	Vitamin E FDA LinkGeneric 05/2017 - 09/2008
3	Caspase 3 (Caspase-3)IBA 07/2013 - 05/2009
3	EnzymesIBA 01/2012 - 01/2006
2	Lipid NanoparticlesIBA 07/2023 - 06/2021
2	Hyaluronic Acid (Hyaluronan)IBA 01/2023 - 09/2020
2	ChitosanIBA 01/2023 - 01/2020
2	GoldIBA 08/2022 - 07/2014
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2022 - 05/2012
2	QuercetinIBA 08/2022 - 01/2014
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2021 - 01/2007
2	Drug CombinationsIBA 03/2021 - 03/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 08/2017
2	tariquidar (XR9576)IBA 01/2017 - 09/2011
2	MetalsIBA 01/2017 - 01/2010
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2017 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 07/2013
2	polyethylene glycol 2000IBA 01/2016 - 01/2013
2	PolyelectrolytesIBA 01/2016 - 11/2015
2	Matrix Metalloproteinases (MMPs)IBA 04/2014 - 06/2012
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2014 - 08/2013
2	Ethylene Glycol (Monoethylene Glycol)IBA 02/2014 - 08/2013
2	HydrazonesIBA 01/2014 - 05/2012
2	Hemoglobins (Hemoglobin)IBA 05/2012 - 03/2004
2	VaccinesIBA 01/2011 - 02/2005
2	RhodaminesIBA 08/2010 - 08/2010
2	Antisense OligonucleotidesIBA 05/2009 - 04/2008
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2007 - 04/2006
2	tetraphenylporphineIBA 07/2007 - 04/2006

Therapy/Procedure

49	Therapeutics 07/2023 - 08/2003
21	Drug Therapy (Chemotherapy) 04/2024 - 09/2009
5	Radiofrequency Ablation 01/2023 - 09/2002
3	Radiotherapy 08/2022 - 07/2013
3	Immunotherapy 06/2021 - 02/2005
3	Precision Medicine 11/2018 - 01/2013
3	Intravenous Injections 01/2014 - 07/2007
2	Injections 12/2013 - 01/2007
2	Aftercare (After-Treatment) 07/2013 - 12/2010
2	Quantum Dots (Quantum Dot) 05/2013 - 06/2005
2	Photochemotherapy (Photodynamic Therapy) 01/2007 - 04/2006